TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 2 | 1 | -2 | 14 | 20 | 39 | 131 | 34 |
S | %wins | 50 | 50 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/24 16:57 | 8/12/24 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Posard Matthew L. | CA | D | S.m | -1,689 | 56.53 | 0 | -30 | -30 | 70 | D | |||||||||||||||
6/13/24 16:15 | 6/11/24 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Posard Matthew L. | CA | D | S.m | -1,006 | 50.32 | 0 | -20 | -17 | 100 | D | |||||||||||||||
12/6/22 19:07 | 12/2/22 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Posard Matthew L. | CA | D | S.m | -1,707 | 56.89 | 0 | -30 | -22 | 105 | D | |||||||||||||||
5/30/13 18:29 | 5/30/13 | ILMN | Illumina Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Posard Matthew L. | CA | O | SVP,GM | S.d | -201 | 70.80 | 33 | -3 | -8 | 31 | D | -2 | 64 | 39 | 45 | 23 | 6 | -1 | 0 | -2 | -4 | 5 | 7 | 38 | 124 |
4/15/13 20:06 | 4/11/13 | ILMN | Illumina Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Posard Matthew L. | CA | O | SVP,GM | S.d | -2,795 | 57.95 | 33 | -48 | -61 | 31 | D | -15 | 10 | 11 | 8 | 11 | 9 | 7 | 4 | 4 | 1 | 23 | 33 | 39 | 138 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |